RMD Resmed Earnings and EPS analysis

EPS in 2026 (TTM): $10.47

Last Report Period Date: Jun 30, 2026

Currently, RMD's 12-month EPS stands at $10.47, according to the most recent financial reports. Resmed's earnings per share in 2026 was reported at $10.47, marking a rise from $9.55 in 2025. RMD recorded an EPS of $2.65 for the quarterly period ending on Jun 30, 2026.

In 2026, Resmed's earnings per share was $10.47, a rise of 9.6% from $9.55 in 2025. The quarterly earnings per share for the period ending Jun 30, 2026, was $2.65, showing a 2.3% increase compared to the same quarter last year. The trailing twelve months EPS for RMD is $10.47 as of June 2026. Resmed's full-year EPS for 2025 was $9.55, a 37.6% rise compared to the previous year.

Resmed has recorded a growth in earnings per share of 2.3% over the past 12 months (YoY, quarterly). During the past three years, RMD had an average yearly EPS growth of 19.6%. Resmed had an average annual EPS growth of 26.2% in the last five years. Over the last decade, RMD had an average annual earnings per share growth of 15.4%.